Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute-Reference-Cited by-同舟云学术

Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute

Published:2021-11 Issue: Volume:112 Page:281-287
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Lutalo Tom,Nalumansi Aminah,Olara Denis,Kayiwa John,Ogwang Bernard,Odwilo Emmanuel,Watera Christine^ORCID,Balinandi Stephen,Kiconco Jocelyn^ORCID,Nakaseegu Joweria^ORCID,Serwanga Jennifer,Kikaire Bernard,Ssemwanga Deogratius,Abiko Brendah,Nsereko Christopher,Cotten Matthew,Buule Joshua,Lutwama Julius,Downing Robert^ORCID,Kaleebu Pontiano^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference25 articles.

1. Aschwanden C (2021) Five reasons why COVID herd immunity is probably impossible. https://www.nature.com/articles/d41586-021-00728-2.

2. A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay;Batra;Journal of Clinical Virology,2020

3. CDC (2020a) CDC's Diagnostic Test for COVID-19 Only and Supplies. https://www.cdc.gov/coronavirus/2019-ncov/lab/virus-requests.html.

4. CDC (2020b) Interim guidelines for COVID-19 antibody testing in Clinical and Public Health Settings. https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html.

5. CDC (2021) COVID-19 Serology Surveillance Strategy. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/serology-surveillance/.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seroprevalence and risk factors for SARS-CoV-2 infection in middle-sized cities of Burkina Faso: A descriptive cross-sectional study;PLOS ONE;2024-08-07

2. Monitoramento pós-mercado dos testes rápidos para detecção de anticorpos da COVID-19: análise de dados da plataforma Microsoft® Power Bi;Vigilância Sanitária em Debate;2024-06-28

3. Re-testing as a method of implementing external quality assessment program for COVID-19 real time PCR testing in Uganda;PLOS ONE;2024-01-24

4. A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiences;Human Vaccines & Immunotherapeutics;2023-08

5. Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda;Frontiers in Immunology;2023-03-14